Literature DB >> 12745497

The demand for nicotine replacement therapies.

John A Tauras1, Frank J Chaloupka.   

Abstract

This paper reports on the first econometric study to examine the determinants of nicotine replacement therapy (NRT) demand. Pooled cross-sectional time-series scanner-based data for 50 major metropolitan markets in the United States covering the period between the second quarter 1996 and the third quarter 1999 are used in the analysis. Fixed-effects modeling is employed to assess the impact of NRT prices, cigarette prices, and other determinants on NRT demand. The estimates indicate that decreases in the price of NRT and increases in the price of cigarettes would lead to substantial increases in per-capita sales of NRT products. The average own-price elasticity of demand, which measures the responsiveness of consumer demand for NRT products to changes in the price of NRT, for Nicoderm CQ and Nicorette, is -2.33 and -2.46, respectively. The average cross-price elasticity of demand, which measures the responsiveness of consumer demand for NRT products to changes in the price of cigarettes, for Nicoderm CQ and Nicorette, is 0.772 and 0.764, respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12745497     DOI: 10.1080/1462220031000073306

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  10 in total

1.  Exploring scenarios to dramatically reduce smoking prevalence: a simulation model of the three-part cessation process.

Authors:  David T Levy; Patricia L Mabry; Amanda L Graham; C Tracy Orleans; David B Abrams
Journal:  Am J Public Health       Date:  2010-05-13       Impact factor: 9.308

2.  Reaching Healthy People 2010 by 2013: A SimSmoke simulation.

Authors:  David T Levy; Patricia L Mabry; Amanda L Graham; C Tracy Orleans; David B Abrams
Journal:  Am J Prev Med       Date:  2010-03       Impact factor: 5.043

3.  Use of pharmacy data to evaluate smoking regulations' impact on sales of nicotine replacement therapies in New York City.

Authors:  Kristina B Metzger; Farzad Mostashari; Bonnie D Kerker
Journal:  Am J Public Health       Date:  2005-06       Impact factor: 9.308

4.  Assessing preferences for improved smoking cessation medications: a discrete choice experiment.

Authors:  Joachim Marti
Journal:  Eur J Health Econ       Date:  2011-06-26

5.  Smokers and non-smokers talk about regulatory options in tobacco control.

Authors:  Stacy M Carter; Simon Chapman
Journal:  Tob Control       Date:  2006-10       Impact factor: 7.552

6.  A comprehensive examination of own- and cross-price elasticities of tobacco and nicotine replacement products in the U.S.

Authors:  Jidong Huang; Cezary Gwarnicki; Xin Xu; Ralph S Caraballo; Roy Wada; Frank J Chaloupka
Journal:  Prev Med       Date:  2018-04-21       Impact factor: 4.018

7.  Price elasticity of demand of non-cigarette tobacco products: a systematic review and meta-analysis.

Authors:  Mohammed Jawad; John Tayu Lee; Stanton Glantz; Christopher Millett
Journal:  Tob Control       Date:  2018-01-23       Impact factor: 7.552

8.  Permissive nicotine regulation as a complement to traditional tobacco control.

Authors:  Walton Sumner
Journal:  BMC Public Health       Date:  2005-02-24       Impact factor: 3.295

9.  Will converting naloxone to over-the-counter status increase pharmacy sales?

Authors:  Sean M Murphy; Jake R Morgan; Philip J Jeng; Bruce R Schackman
Journal:  Health Serv Res       Date:  2019-02-20       Impact factor: 3.402

10.  Smaller Cigarette Pack as a Commitment to Smoke Less? Insights from Behavioral Economics.

Authors:  Joachim Marti; Jody Sindelar
Journal:  PLoS One       Date:  2015-09-10       Impact factor: 3.752

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.